Streamlining and Non-Compliant Intact Mass Analysis of Biotherapeutic mAbs with the Biopharmaceutical Platform Solution

23 May 2013

The Biopharmaceutical Platform Solution with UNIFI® enables a fully integrated workflow for intact mass analysis, including acquisition, processing, and reporting, for organizations in early development and those operating under regulatory compliant environments. The ability to automate and standardize intact mass analysis enables laboratories to deploy their scientific resources with greater efficiency and effect.

• Download this article

RELATED PRODUCTS

• ACQUITY UPLC H-Class Bio Syste...
• Biopharmaceutical Platform Sol...
• Xevo G2 QTof